Literature DB >> 30697788

Diffusion-weighted magnetic resonance imaging is useful for assessing inflammatory myopathies.

Marie Faruch1, Ana Isabel Garcia2, Montse Del Amo2, Jaume Pomes2, Jaime Isern2, Sergio Prieto González3, Josep María Grau3, José César Milisenda3, Xavier Tomas2.   

Abstract

INTRODUCTION: Short tau inversion recovery (STIR) sequences in whole-body MRI are usually used for detecting muscle edema (ME) in inflammatory myopathies. We evaluated b-value 800 diffusion-weighted imaging (b800 DWI).
METHODS: Two radiologists independently and a consensus reader retrospectively reexamined 60 patients with inflammatory myopathies and 15 controls. For each participant, 78 muscles were analyzed with 3 sets of imaging acquisitions: T1-weighted (T1) turbo spin echo and STIR; T1 and DWI; and T1, STIR and DWI. Mean edema per patient was compared between sequences. Agreement was evaluated.
RESULTS: Diffusion-weighted imaging detected more ME compared with STIR (P < 0.001). Agreement between readers was better with both sequences (k = 0.94) than with b800 DWI (k = 0.89) or STIR (k = 0.84) alone. DISCUSSION: Diffusion-weighted imaging is a valuable add-on for the study of inflammatory myopathies. Muscle Nerve 59:555-555, 2019.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  diffusion magnetic resonance imaging; edema; inflammatory myopathy; muscular disease; whole body imaging

Mesh:

Substances:

Year:  2019        PMID: 30697788     DOI: 10.1002/mus.26438

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  2 in total

1.  Features of MRI honeycomb edema signals in cancer-associated dermatomyositis patients: a brief report.

Authors:  Xiaoxiao Cheng; Meichen Zhou; Jianhua Jiang; Sijia Zhu; Qi Fang; Meirong Liu
Journal:  Clin Rheumatol       Date:  2022-09-26       Impact factor: 3.650

Review 2.  MRI and muscle imaging for idiopathic inflammatory myopathies.

Authors:  Samuel Malartre; Damien Bachasson; Guillaume Mercy; Elissone Sarkis; Céline Anquetil; Olivier Benveniste; Yves Allenbach
Journal:  Brain Pathol       Date:  2021-05       Impact factor: 6.508

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.